- Home
- ZAPP vs ALZN Comparison
ZAPP vs ALZN Comparison
Compare ZAPP & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZAPP
- ALZN
- Stock Information
- Founded
- ZAPP 2017
- ALZN 2016
- Country
- ZAPP Thailand
- ALZN United States
- Employees
- ZAPP N/A
- ALZN N/A
- Industry
- ZAPP Motor Vehicles
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- ZAPP Consumer Discretionary
- ALZN Health Care
- Exchange
- ZAPP Nasdaq
- ALZN Nasdaq
- Market Cap
- ZAPP 7.0M
- ALZN 6.1M
- IPO Year
- ZAPP N/A
- ALZN 2021
- Fundamental
- Price
- ZAPP $0.67
- ALZN $1.03
- Analyst Decision
- ZAPP
- ALZN Strong Buy
- Analyst Count
- ZAPP 0
- ALZN 1
- Target Price
- ZAPP N/A
- ALZN $20.00
- AVG Volume (30 Days)
- ZAPP 150.2K
- ALZN 212.9K
- Earning Date
- ZAPP 01-31-2025
- ALZN 03-10-2025
- Dividend Yield
- ZAPP N/A
- ALZN N/A
- EPS Growth
- ZAPP N/A
- ALZN N/A
- EPS
- ZAPP N/A
- ALZN N/A
- Revenue
- ZAPP $17,440.00
- ALZN N/A
- Revenue This Year
- ZAPP $67,159.17
- ALZN $322.64
- Revenue Next Year
- ZAPP $1,149.53
- ALZN N/A
- P/E Ratio
- ZAPP N/A
- ALZN N/A
- Revenue Growth
- ZAPP N/A
- ALZN N/A
- 52 Week Low
- ZAPP $0.66
- ALZN $0.64
- 52 Week High
- ZAPP $19.10
- ALZN $15.06
- Technical
- Relative Strength Index (RSI)
- ZAPP 34.74
- ALZN 51.09
- Support Level
- ZAPP $0.66
- ALZN $0.95
- Resistance Level
- ZAPP $0.92
- ALZN $1.05
- Average True Range (ATR)
- ZAPP 0.08
- ALZN 0.10
- MACD
- ZAPP -0.02
- ALZN 0.01
- Stochastic Oscillator
- ZAPP 4.48
- ALZN 60.29
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories. Companies founders are automotive professionals from all over the world who share a commitment to sustainability, a long passion for electric vehicles, motorcycles, and believe in the choice of personal urban mobility. The company operates in Cayman Islands, Europe, Thailand. Maximum of revenue is from Thailand.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.